Skip to content
  • Saturday, 12 September 2026
  • 5:53 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Long-Term Chlorpyrifos Exposure Linked to 2.5-Fold Increase in Parkinson’s Disease Risk UCLA Researchers Find
Neuroscience & Brain Research

Long-Term Chlorpyrifos Exposure Linked to 2.5-Fold Increase in Parkinson’s Disease Risk UCLA Researchers Find

Rifan Muazin Jul 6, 2026 0

A groundbreaking study led by researchers at UCLA Health has established a definitive link between long-term residential exposure to the…

Read More
Neuroscience & Brain Research

Long-Term Exposure to Agricultural Pesticide Chlorpyrifos Linked to 2.5-Fold Increase in Parkinson’s Disease Risk According to UCLA Health Study

Rifan Muazin Jun 29, 2026 0

A comprehensive investigation led by researchers at UCLA Health has established a definitive and alarming link between long-term residential exposure…

Read More
Laboratory Automation & Robotics

UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing

Lana Keisha May 31, 2026 0

Los Angeles, CA – A novel drug candidate for glioblastoma, KTM-101, developed by researchers at the University of California, Los…

Read More
Laboratory Automation & Robotics

UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing

Lana Keisha May 20, 2026 0

Los Angeles, CA – In a significant development offering renewed hope in the challenging landscape of brain cancer treatment, researchers…

Read More
Laboratory Automation & Robotics

UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing

Lana Keisha May 13, 2026 0

In a significant stride forward against one of the most formidable and lethal human cancers, researchers at UCLA have successfully…

Read More
Laboratory Automation & Robotics

UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing

Lana Keisha May 5, 2026 0

Researchers at UCLA have achieved a significant milestone in the arduous fight against glioblastoma, a notoriously aggressive and lethal form…

Read More
Neuroscience & Brain Research

Long-Term Residential Exposure to Chlorpyrifos Linked to Significant Increase in Parkinson’s Disease Risk According to New UCLA Health Study

Rifan Muazin Apr 5, 2026 0

A comprehensive study led by researchers at UCLA Health has established a definitive link between long-term residential exposure to the…

Read More
Neuroscience & Brain Research

Long-Term Residential Exposure to Chlorpyrifos Increases Parkinson’s Disease Risk by Over Two and a Half Times UCLA Health Study Finds

Rifan Muazin Mar 27, 2026 0

A groundbreaking longitudinal study conducted by researchers at UCLA Health has established a definitive link between chronic residential exposure to…

Read More
Neuroscience & Brain Research

UCLA and UCSF Researchers Uncover Genetic Mechanisms Behind Neuronal Resistance to Tau Protein Buildup in Alzheimer’s Disease

Rifan Muazin Mar 23, 2026 0

The landscape of neurodegenerative research has been significantly altered by a collaborative breakthrough from scientists at UCLA Health and the…

Read More
Neuroscience & Brain Research

Long-Term Exposure to Chlorpyrifos Linked to Significantly Higher Risk of Parkinson’s Disease According to UCLA Health Study

Rifan Muazin Mar 19, 2026 0

A comprehensive study led by researchers at UCLA Health has established a definitive link between long-term residential exposure to the…

Read More
Novo Nordisk’s Wegovy Pill Fuels Ambitious Growth Strategy Amidst Fierce CompetitionEverest Medicines Acquires Hasten Biopharmaceuticals for $250 Million to Bolster Asia Pacific Chronic Disease Portfolio and Commercial ReachBreakthrough in PFAS Degradation Scientists Identify Hydrogen Radicals as Key to Destroying Forever Chemicals Using UV LightUnlocking the Secret to Extended Mango Freshness: Hainan University Researchers Pinpoint Optimal 12°C Storage Temperature
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetLLMOps in 2026: The 10 Tools Every Team Must Have
TWiV 1287: Ancient herpesviruses and modern dementiaJohns Hopkins Researchers Discover How Fusion Genes Drive Rare Kidney Cancer Through Liquid DropletsRNA breakthrough provides hope for thousands of untreatable diseases, including cystic fibrosis, muscular dystrophy and some cancersMerck and Moderna’s cancer vaccine is customized for each patient’s tumor
YOU MAY HAVE MISSED
Microbiology & Immunology
TWiV 1287: Ancient herpesviruses and modern dementia
Lina Irawan Sep 12, 2026
Stem Cell & Regenerative Medicine
Johns Hopkins Researchers Discover How Fusion Genes Drive Rare Kidney Cancer Through Liquid Droplets
Dwi Wanna Sep 12, 2026
Biotech & Genetic Research
RNA breakthrough provides hope for thousands of untreatable diseases, including cystic fibrosis, muscular dystrophy and some cancers
Jia Lissa Sep 12, 2026
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Sep 12, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ